Research advances in tuberculosis care for key populations

doi:10.19982/j.issn.1000-6621.20250251

Abstract

Abstract:

Tuberculosis (TB) remains a major global public health threat, disproportionately affecting key populations such as the elderly, children, migrants, individuals with drug-resistant TB, and those living with HIV. These groups often face structural and physiological vulnerabilities, including limited access to healthcare services and heightened social stigma, which hinder effective disease management. Tailored, patient-centered care is therefore essential to improving outcomes. Despite global progress in TB control, significant gaps persist in the delivery of equitable care for these high-risk populations. This review offers a comprehensive analysis of the current landscape, persistent barriers, and strategic directions for enhancing TB care in key populations. It proposes an integrated framework that emphasizes policy innovation, technological advancement, and multisectoral collaboration. These insights aim to support the development of more effective, inclusive care strategies and accelerate progress toward TB elimination.

Key words: Tuberculosis, Patient care, Health policy, Social support

CLC Number:

Liang Xuefang, Wang Zhiying, Zhu Zhipeng. Research advances in tuberculosis care for key populations[J]. Chinese Journal of Antituberculosis, 2025, 47(12): 1644-1650. doi: 10.19982/j.issn.1000-6621.20250251

References 53

[1]	Mason PH, Lyttleton C, Marks GB, et al. The technological imperative in tuberculosis care and prevention in Vietnam. Glob Public Health, 2020, 15(2):307-320. doi:10.1080/17441692.2019.1650950. pmid: 31422743
[2]	刘二勇, 陈明亭, 周林, 等. 开展患者关怀行动提升结核病防治综合服务质量. 中国防痨杂志, 2022, 44(5):433-437. doi:10.19982/j.issn.1000-6621.20220022.
[3]	Bragazzi NL, Martini M, Mahroum N. Social determinants, ethical issues and future challenge of tuberculosis in a pluralistic society: the example of Israel. J Prev Med Hyg, 2020, 61(1 Suppl 1):E24-E27. doi:10.15167/2421-4248/jpmh2020.61.1s1.1443.
[4]	Marx FM, Cohen T, Menzies NA, et al. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health, 2020, 8(9): e1223-e1233. doi:10.1016/S2214-109X(20)30227-8.
[5]	成君, 张灿有, 陈卉, 等. 采取因地制宜的措施加强重点人群结核病防控. 中国防痨杂志, 2021, 43(3):217-221. doi:10.3969/j.issn.1000-6621.2021.03.005.
[6]	冯萍, 何慧玲, 陈琳, 等. 妊娠合并结核病112例病例分析及重症高危人群随访. 实用医学杂志, 2022, 38(11):1404-1409. doi:10.3969/j.issn.1006-5725.2022.11.019.
[7]	Hunter RL. The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity. Front Immunol, 2018, 9:2108. doi:10.3389/fimmu.2018.02108. pmid: 30283448
[8]	买日哈巴·卡米力, 买吾拉江·依马木, 阿丽米热·阿不力米提, 等. 2013—2020年新疆喀什地区结核病患者复发的空间聚集性及影响因素分析. 现代预防医学, 2024, 51(14):2501-2506. doi:10.20043/j.cnki.MPM.202404155.
[9]	陈丽燕, 张晓强, 余建平, 等. 2013—2022年杭州市临平区登记肺结核患者特点及治疗转归影响因素分析. 中国防痨杂志, 2024, 46(12):1459-1468. doi:10.19982/j.issn.1000-6621.20240326.
[10]	Maison DP. Tuberculosis pathophysiology and anti-VEGF intervention. J Clin Tuberc Other Mycobact Dis. 2022,27:100300. doi:10.1016/j.jctube.2022.100300.
[11]	郭萌, 吴文, 李敬文, 等. 基于文献计量学的“结核”主题高被引文献特征分析. 中国防痨杂志, 2024, 46(5):567-577. doi:10.19982/j.issn.1000-6621.20240075.
[12]	张灿有, 陈卉, 张慧, 等. 2011—2020年全国65岁及以上老年人肺结核报告发病情况分析. 中华疾病控制杂志, 2022, 26(11):1252-1258. doi:10.16462/j.cnki.zhjbkz.2022.11.003.
[13]	王前, 王嘉, 李玉红, 等. 重视儿童结核病防治关爱儿童健康. 中国防痨杂志, 2023, 45(1):1-5. doi:10.19982/j.issn.1000-6621.20220462.
[14]	任成山, 林辉, 杨仕明. 结核病的流行特征与耐多药的窘迫及其策略. 中华肺部疾病杂志(电子版), 2019, 12(3):269-274. doi:10.3877/cma.j.issn.1674-6902.2019.03.001.
[15]	姜永莉, 甄理, 于欣, 等. 国境口岸结核病防控现状浅析. 中国国境卫生检疫杂志, 2022, 45(3):250-252. doi:10.16408/j.1004-9770.2022.03.020.
[16]	Woldesemayat EM. Tuberculosis in Migrants is Among the Challenges of Tuberculosis Control in High-Income Countries. Risk Manag Healthc Policy, 2021, 14:2965-2970. doi:10.2147/RMHP.S314777.
[17]	陈晓凤, 王秀华, 聂菲菲. 肺结核患者关怀与支持干预研究进展. 中国防痨杂志, 2019, 41(7):775-778. doi:10.3969/j.issn.1000-6621.2019.07.014.
[18]	欧青叶, 张伟华, 罗涛, 等. 珠海市实施结核病患者健康管理服务的SWOT分析. 热带医学杂志, 2019, 19(4):515-517. doi:10.3969/j.issn.1672-3619.2019.04.031.
[19]	刘翠华, 任小波, 汪静, 等. 科技助力结核病防控:现状、进展与对策. 中国科学院院刊, 2022, 37(1):112-122. doi:10.16418/j.issn.1000-3045.20211116002.
[20]	汪丽芳, 徐卓, 梁海鹰, 等. 上海市某区农民工肺结核患者社会支持及职业卫生服务需求现状. 工业卫生与职业病, 2022, 48(6):532-534,536. doi:10.13692/j.cnki.gywsyzyb.2022.06.025.
[21]	Choi SW, Im JJ, Yoon SE, et al. Lower socioeconomic status associated with higher tuberculosis rate in South Korea. BMC Pulm Med, 2023, 23(1):418. doi:10.1186/s12890-023-02713-z.
[22]	Ruiz-Tornero AM, Sánchez-Recio R. Tuberculosis and socioeconomic factors in spanish population: a systematic review. Rev Esp Salud Publica, 2022,96:e202212089.
[23]	李运葵, 李京, 夏岚, 等. 2020年四川省15岁以上常住居民结核病防治核心信息知晓情况及其影响因素分析. 预防医学情报杂志, 2022, 38(3):319-324.
[24]	Ilic M, Bjelic D, Javorac J, et al. Knowledge is the most powerful tool in the fight against tuberculosis. J Infect Dev Ctries, 2023, 17(8):1099-1106. doi:10.3855/jidc.18112.
[25]	Xie H, Wang W, Chen X, et al. An analysis of knowledge, attitudes, practice and influencing factors for tuberculosis prevention and control among Hainan University students. Front Public Health, 2025,13:1478251. doi:10.3389/fpubh.2025.1478251.
[26]	倪帅虎, 陈钢, 王嘉, 等. “十三五”期间我国农村居民结核病健康教育状况及结核病防治核心信息影响因素分析. 中国防痨杂志, 2024, 46(12):1469-1477. doi:10.19982/j.issn.1000-6621.20240363.
[27]	冯亚杰, 张环宇, 王楠, 等. 中国流动矿工结核病健康教育空间分布及影响因素——基于随机森林模型. 中国卫生事业管理, 2024, 41(1):84-89.
[28]	Nguipdop-Djomo P, Rodrigues LC, Smith PG, et al. Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study. Sci Rep, 2022, 12(1):5639. doi:10.1038/s41598-022-09667-y.
[29]	George S, Syamala TS, Paranjpe A, et al. Intersections of informal work status, gender and tuberculosis diagnosis: Insights from a qualitative study from an Indian setting. PLoS One, 2023, 18(7):e0289137. doi:10.1371/journal.pone.0289137.
[30]	王立群, 孙国琴. 医保背景下耐药结核病经济负担的分析. 中国防痨杂志, 2024, 46(S1):313-315.
[31]	De Foo C, Wu S, Amin F, et al. A qualitative exploration of factors that influence the uptake of tuberculosis services by low-skilled migrant workers in Singapore. BMC Health Serv Res, 2023, 23(1):943. doi:10.1186/s12913-023-09938-y. pmid: 37659999
[32]	Bhargava A, Bhargava M, Juneja A. Social determinants of tuberculosis: context, framework, and the way forward to ending TB in India. Expert Rev Respir Med, 2021, 15(7):867-883. doi:10.1080/17476348.2021.1832469.
[33]	樊丽超, 焦伟伟, 吴浩宇, 等. 世界卫生组织《结核病整合指南模块5:儿童和青少年结核病管理》解读. 中国防痨杂志, 2023, 45(1):6-12. doi:10.19982/j.issn.1000-6621.20220403.
[34]	Zhou J, Pu J, Wang Q, et al. Tuberculosis treatment management in primary healthcare sectors: a mixed-methods study investigating delivery status and barriers from organisational and patient perspectives. BMJ Open, 2022, 12(4):e053797. doi:10.1136/bmjopen-2021-053797.
[35]	王歆尧, 姜美丽, 庞元捷, 等. 中国结核病疾病负担现状. 中华流行病学杂志, 2024, 45(6):857-864. doi:10.3760/cma.j.cn112338-20240311-00111.
[36]	刘桂珍, 邓国防. 《结核病政策指南制订过程中发现的证据和研究缺口(第2版)》解读——结核病相关共病. 中国防痨杂志, 2024, 46(6):618-624. doi:10.19982/j.issn.1000-6621.20240076.
[37]	杨松, 郭建琼, 王乐乐, 等. 世界卫生组织2022年版《敏感结核病治疗指南》解读. 中华结核和呼吸杂志, 2023, 46(6):634-637. doi:10.3760/cma.j.cn112147-20230318-00136.
[38]	宋敏, 陆普选, 方伟军, 等. 2022年WHO全球结核病报告:全球与中国关键数据分析. 新发传染病电子杂志, 2023, 8(1):87-92. doi:10.19871/j.cnki.xfcrbzz.2023.01.018.
[39]	Gu P, Lu P, Ding H, et al. Effectiveness, cost, and safety of four regimens recommended by WHO for RR/MDR-TB treatment: a cohort study in Eastern China. Ann Med, 2024, 56(1):2344821. doi:10.1080/07853890.2024.2344821.
[40]	John CA. Realizing the World Health Organization's end TB strategy (2016—2035): How can social approaches to tuberculosis elimination contribute to progress in Asia and the Pacific?. Trop Med Infect Dis, 2019, 4(1):28. doi:10.3390/tropicalmed4010028.
[41]	赵阿利, 袁荣, 罗卉, 等. 以患者为中心的耐多药/利福平耐药结核病患者关怀服务实施效果分析. 中国防痨杂志, 2021, 43(6):606-611. doi:10.3969/j.issn.1000-6621.2021.06.015.
[42]	夏岚, 仲玲, 赵琴, 等. 四川省贫困地区60岁及以上老年结核病患者救助效果分析. 预防医学情报杂志, 2019, 35(5):413-418.
[43]	王黎霞. 结核病防治可持续发展之路——回顾“十三五”展望“十四五”. 中国防痨杂志, 2021, 43(1):3-5. doi:10.3969/j.issn.1000-6621.2021.01.002.
[44]	Siahaan ES, Bakker MI, Pasaribu R, et al. Islands of Tuberculosis Elimination: An Evaluation of Community-Based Active Case Finding in North Sumatra, Indonesia. Trop Med Infect Dis, 2020, 5(4):163. doi:10.3390/tropicalmed5040163.
[45]	Cox HS, Mbhele S, Mohess N, et al. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial. PLoS Med, 2014, 11(11):e1001760. doi:10.1371/journal.pmed.1001760.
[46]	Okada K, Yamada N, Takayanagi K, et al. Applicability of artificial intelligence-based computer-aided detection (AI-CAD) for pulmonary tuberculosis to community-based active case finding. Trop Med Health, 2024, 52(1):2. doi:10.1186/s41182-023-00560-6.
[47]	Van Rie A, De Vos E, Costa E, et al. Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial. Trials, 2022, 23(1):864. doi:10.1186/s13063-022-06793-w. pmid: 36209235
[48]	张金静, 杨云云, 彭大利. 利用新技术提高结核病患者治疗依从性的研究进展. 中国全科医学, 2020, 23(1):114-119. doi:10.12114/j.issn.1007-9572.2019.00.361.
[49]	李亚敏, 高志东, 李艳圆, 等. 微信和电子药盒在北京市肺结核患者督导服药管理中的应用效果评价. 中国防痨杂志, 2023, 45(9):872-879. doi:10.19982/j.issn.1000-6621.20230115.
[50]	Ngwatu BK, Nsengiyumva NP, Oxlade O, et al. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J, 2018, 51(1):1701596. doi:10.1183/13993003.01596-2017.
[51]	Baral SC, Aryal Y, Bhattrai R, et al. The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies. BMC Public Health, 2014,14:46. doi:10.1186/1471-2458-14-46.
[52]	赵凤芹, 张雁, 张永强, 等. 大学生志愿者对某高校新生结核病知信行干预效果评价. 中国健康教育, 2021, 37(6):558-561. doi:10.16168/j.cnki.issn.1002-9982.2021.06.017.
[53]	钟年好, 郑镇泳, 吴少玲, 等. 医患视角下初治中青年肺结核患者延迟重返工作成因的质性研究. 护理学杂志, 2024, 39(12):90-93. doi:10.3870/j.issn.1001-4152.2024.12.090.